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Introduction. Since the latter half of the 20th century, Poland has witnessed increasing life expectancy inequalities 
between women and men. In 2012, women’s life expectancy was over 8 years higher than for men. Such disparities 
mainly arise from differences in the prevalence of those lifestyle behaviours increasing the risk of premature death, 
such as tobacco smoking and alcohol consumption. This paper is mainly focused on estimating the impact of tobacco-
related cancers on life expectancy inequalities between Polish women and men.
Material and methods. The database of the World Health Organization (WHO) was used to supply the statistics on 
tobacco-related cancer mortality in Poland during 1970–2012, including population size. Male excess mortality was 
expressed as the difference in life expectancy at birth between females and males. Such inequalities between genders 
were assessed by Arriaga’s decomposition method. The Joinpoint Regression program was used to analyse time trends. 
Results. After excluding gender-specific malignant neoplasms (cervical and ovarian cancers), tobacco-related cancers 
were found to be responsible for 22% of the differences in life expectancy between females and males for 2012. Male 
life expectancy at birth was on average shorter by 1.8 years because of cancer mortality being causatively associated 
with tobacco smoking when compared to females. After accounting for gender-specific cancers in the analysis, there 
were no significant changes in the observed differences. Tobacco-dependent cancers were found to be responsible for 
18% of the difference in 2012, which is associated with 1.5 year shorter male life expectancy as compared to females. 
Conclusions. Tobacco-related cancers significantly impact on life expectancy inequalities between females and males 
and significantly affect excess mortality rates in Polish men. 
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Introduction
In Poland, increasing gaps in life expectancy have 
been  observed, which had begun in the second half of 
the 20th century. In 1991, such differences peaked where 
female life expectancy was on average 9.2 years longer than 
for males [1].  In the following decade, this gap became 
reduced by one year, but has started widening again 
since the beginning of the 21st century, reaching 8.3 
years in 2012. At this time life expectancy at birth was 
72.7 years for males and 81.0 years for females [1].
Differences in life expectancy between genders have 
been the subject of many studies [2, 3] where male ex-
cess mortality is commonly dealt with in relation to gender 
lifestyle differences (i.e. cigarette smoking, alcohol con-
sumption, diet and physical activity levels, etc.) [4], and that 
varying lifestyle behaviour, such as tobacco smoking and 
alcohol consumption, are considered to be the main causes 
of an increased mortality risk [5]. According to McCartney 
et al., tobacco-use-dependent-mortality is responsible for 
40–60% of mortality differences between men and women 
in 30 European countries. Tobacco smoking is one of the 
main risk factors of cardiovascular disease and cancer [6]. It is 
estimated that such behaviour is a direct cause of premature 
death in more than 50% long-term smokers, whilst the life 
expectancy of tobacco users is on average 10 years shorter 
compared to non-smokers [7].
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In Poland, male tobacco smoking is more prevalent than 
in females [8], as is the case for the majority of European 
countries [9]. This phenomenon impacts both on tobacco-
related mortality and mortality inequalities between males 
and females [5, 10]. 
This paper aims to determine the magnitude of differ-
ences in life expectancy between Polish men and women as 
well as epidemiologically analysing the impact of tobacco-
related cancers on male excess mortality and to propose 
policy recommendations for reducing this gap.
Materials and methods
The study results are based on the cancer mortality 
database in Poland taken from 1970–2012 according to age 
and gender. Mortality and population data were obtained 
from the official statistics of the World Health Organization’s 
(WHO) database available from the WHO website [11]. Those 
cancers deaths attributable to tobacco use were analysed 
according to the classification proposed by the International 
Agency on Research on Cancer [12]; such cancer sites are 
listed in Table I. 
Mortality data according to the cause of death during 
1997–1998 were not available as Polish doctors were on 
strike at that time. Mortality rates from this time period 
were estimated and based on average mortality rates from 
years 1996 and 1999.
Male excess morality rates were expressed as the dif-
ference in life expectancy between males and females. 
Life expectancy was measured by life expectancy tables 
and analysed according to S.H. Prestin, P. Heuveline and 
M. Guillot in Demography measuring and modelling popula-
tion processes [13]. Arriaga’s decomposition method was 
applied to life expectancy differences [14] which allowed 
the share of chosen causes of death in the differences in life 
expectancy between two populations to be quantified. Data 
used for the decomposition was the cancer mortality that 
was causatively associated with tobacco smoking (see Tab. I).
Temporal trends analysis was performed by the Join-
point Regression Program version 4.3.1.0, in order to fit trend 
lines that were statistically significant to the analysed data. 
The type of variable was suitably defined (percentage or 
other) and data were log transformed and a homogeneity of 
variance was assumed for the weighted least square method. 
A Permutation Test was performed to determine the minimum 
number of the so-called change points (up to 3). The statistical 
significance level was set at α = 0.05. Annual Average Percent-
age Change (AAPC) was calculated according to time period 
models and their statistical significance was determined. 
Results
Life expectancy at birth has been increasing in Poland 
for the last 40 years for both genders, however this increase 
has become more pronounced in last two decades of the 
observation period (Fig. 1). 
In the 1970s, female life expectancy at birth increased 
from 73 years in 1970, to 75 years in 1979. In the following 
decade, this rising trend was maintained, albeit at a slower 
rate. Male life expectancy remained at a constant level in the 
same time period, oscillating between 66 and 68 years. Due 
to such contrasting trends, differences in life expectancy 
between males and females rose significantly, reaching 
9 years at the end of 1980s when at the beginning of the 
1970s it had been 6.6 years. This difference peaked in 1991, 
where female life expectancy at 75.3 years was 9.2 years 
higher than for males; being at 66.1 years. Hitherto this time, 
life expectancy rose for both males and females, however 
Table I. Codes of tobacco-attributable causes of cancer deaths according to ICD revisions
ICD-8 A ICD-9 BTL ICD-10 Cancer causes of death
A045 B08 C00–C14 Malignant neoplasms, lip, oral cavity and pharynx
A046 B090 C15 Malignant neoplasm of esophagus
A047 B091 C16 Malignant neoplasm of stomach
[153–154] B093–B094 C18–C21 Malignant neoplasm of colon and rectum
[155] B095 C22 Malignant neoplasms of liver and intrahepatic bile ducts
[157] B096 C25 Malignant neoplasm of pancreas
[160] [160] C30–C31 Malignant neoplasm of nasal cavity, middle ear and accessory sinuses*
A050 B100 C32 Malignant neoplasm of larynx
A051 B101 C33-C34 Malignant neoplasm of trachea, bronchus and lung
A055 B120 C53 Malignant neoplasm of cervix uteri
[183] B123 C56 Malignant neoplasm of ovary (mucinous)
[188–189] B126, [189] C64–C68 Malignant neoplasms of urinary organs
[205] [205] C92 Myeloid leukemia
*The codes also embrace malignant neoplasms of the inner ear — these were included as the analysis was possible in such a configuration, however mortality from this 
cause was negligible; in 2012 there were 13 registered deaths from this cause.
Source: Authors’ analysis; in square brackets there numbers are presented from detailed lists of codes — this concerns all causes of cancer deaths, that were not present in 
the aggregated lists of the ICD codes
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the rate of increase was higher for males; consequently, 
differences in mortality rates between the sexes started 
to decrease. This trend became shortly reversed during 
2002–2007, where female life expectancy started to rise 
faster compared to males. Since 2007 onwards, a reduction 
in gender differences for life-expectancy was observed. In 
2012, life expectancy was 81.0 years for females and 72.7 
years for males; an 8.3 years difference. 
Some of the tobacco-linked cancers, such as cervical and 
ovarian cancer, are specific only to females. As our study aim 
was to describe male excess-mortality in relation to female 
mortality rates, the gender differences in life expectancy that 
can be linked to tobacco use were both analysed, includ-
ing and excluding those cancers occurring only in females. 
After excluding the female-specific cancers, tobacco-
-linked cancers were responsible for approximately 17–18% 
of the differences in life-expectancy at birth between males 
and females at the beginning of the 1970s. Our calculations 
have demonstrated that tobacco-linked cancers resulted 
in males losing on average 1.2 years in the mortality rate 
difference as compared to females (Fig. 2). 
Up to the beginning of the 21st century, the contribu-
tion of tobacco-related cancers to this difference had been 
increasing, where in 2002 this accounted for 23–24% of the 
total difference in life expectancy between males and fe-
males with males having, on average, 2 years less life expec-
tancy than females. After 2004, the effect of tobacco-related 
cancers in these differences started to diminish, where the 
gap in life expectancy between genders was 1.8 years in 
2012; accounting for 22% of this difference (Fig. 2). Female-
-specific cancers that per se reduce the life expectancy gap 
between males and females did not significantly affect the 
total tobacco-related differences in life expectancy.
In 2002, when taken together, tobacco-linked cancers at 
first had increased to approximately 20%, which represented 
a 1.7 year shorter male life expectancy at birth than in fe-
males. In 2012, tobacco-related cancers showed a decreased 
(18%) contribution to this difference in life expectancy, rep-
resenting a reduced 1.5 year gender gap (Fig. 3).
Discussion
Mortality due to tobacco-attributable cancers signifi-
cantly contributes to the high levels of total mortality ob-
served from cancer disease in Poland. In 2012, tobacco-
-related cancers represented 73% of all cancer deaths in 
males and 58% in females. In terms of mortality from all 
causes, then tobacco-linked cancer mortality was 20% for 
males and 13% for females. 
In Poland, male excess mortality is observed not only 
for cancer disease and tobacco-linked cancers, but also for 
cardiovascular disease and deaths due to external causes 
[15, 16]. These three factors are the main cause for the gen-
der gap in life expectancy which should be treated as one of 
the most important public health issues in this country [17]. 
Increased life expectancy should be the same for both 
genders, as they are under the same healthcare system 
and experience the same socio-economic conditions. 
Nevertheless, because of such risk factors as tobacco 
smoking and alcohol consumption, gender similarities 
became divergent as early as at the beginning of 1970s. 
This increase of female life expectancy was attributed to 
reduced perinatal mortality and the increase of gender 
Figure 1. Differences in life expectancy between men and women in Poland. Source: Authors’ analysis
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equality [15]. Contemporaneously, increased prevalence 
of tobacco smoking in males contributed to opening the 
gap between female and male mortality rates and life 
expectancy in 1970s and 1980s [18]. 
An increased prevalence of smoking by females and 
a simultaneous rise of smoking cessation rates in males are 
considered to be the reason for a closing gap in life expec-
tancy rates after 1991 [18]. This process reversed a decade 
later where female life expectancy started to increase more 
rapidly than males during 2002–2007, which was explained 
by increasing male alcohol consumption related to a 30% 
reduction of excise duty for spirit drinks [20, 21]. 
Figure 2. Share of tobacco-attributable cancer deaths in life expectancy differences between men and women in Poland (gender-specific cancers 
not taken into account). Source: Authors’ analysis
*average annual percent change for given time periods being significantly different from zero (a = 0.05) 
Figure 3. Share of tobacco-attributable cancer deaths in life expectancy differences between men and women in Poland (gender-specific cancers 
taken into account). Source: Authors’ analysis
*average annual percent change for given time periods being significantly different from zero (a = 0.05)
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The presented analyses confirms that during last four 
decades, those cancers attributable to tobacco use contrib-
uted to significant differences between male and female life 
expectancy in Poland. Limiting exposure to tobacco smoke 
could prevent a large proportion of deaths [22] and de-
crease the morbidity and mortality rates of tobacco-linked 
cancers, as suggested by Doll and Peto in 1981 [23]. In 2005, 
it was estimated that more than one third of all cancer 
deaths worldwide were caused by potentially modifiable 
risk factors, amongst which tobacco smoking and alcohol 
consumption are critical [22]. As in Poland, males more often 
engage in risky behaviour than females [24, 25], and smok-
ing prevalence has always been higher for Polish males than 
females [8, 26]. Reducing such risk factors could thereby 
increase male life expectancy and contribute to closing 
inequalities in gender life expectancy. 
Measures aimed at effectively treating tobacco depend-
ence, undertaking large-scale educational initiatives and 
promoting primary cancer prevention, (especially targeted 
at males) thereby appear to be vital for diminishing the 
existing differences in life expectancy between genders in 
Poland and other countries.
Limitations
Deaths from tobacco-attributable cancers were analysed 
in this study. Not all these deaths were exclusively caused by 
tobacco smoking. Some deaths were due to cancers of the 
lip, oral cavity, throat, oesophagus, larynx, liver and colon 
and thus could have been caused by alcohol consumption or 
by the combined effect of alcohol consumption and tobacco 
smoking. Our analysis was based on population data, where 
information on past health behaviour of individuals was not 
available. Differences in mortality were calculated based on 
total mortality rates for selected cancers.
Because the histological distinction between different 
subtypes of ovarian cancer in the ICD classification is lacking, 
all types of this tumour were included in our analyses; and not 
only mucinous cancer, which is causally related to tobacco use.
Conclusion
Tobacco-attributable cancers are a cause of significant 
differences in life expectancy between males and females 
and contribute to male excess mortality rates in Poland. Ac-
tions aimed at limiting the influence of risk factors, mainly 
tobacco use, appear necessary in order to close the gap in 
male and female life expectancy in Poland.
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